Steminent Biotherapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	132.46	205.4	451.86	230.56	40.81
Short-Term Investments	32.02	11.6	-	-	-
Cash & Short-Term Investments	164.48	217	451.86	230.56	40.81
Cash Growth	-63.60%	-51.98%	95.98%	464.90%	-
Other Receivables	0.62	0.94	0.84	0.78	0.26
Receivables	0.62	0.94	0.84	0.78	0.26
Inventory	10.08	12	7.67	10.4	10.61
Prepaid Expenses	10.68	-	-	1.14	2.01
Other Current Assets	-	5.82	6.09	-	-
Total Current Assets	185.85	235.76	466.46	242.88	53.69
Property, Plant & Equipment	154.57	168.18	83.16	22.8	33.52
Other Intangible Assets	2.08	2.39	0.51	0.16	0.17
Other Long-Term Assets	34.85	30.34	43.74	13.66	12.82
Total Assets	377.35	436.66	593.88	279.5	100.18
Accounts Payable	1.36	2.54	2.15	0.65	0.86
Accrued Expenses	-	11.44	13.81	10.01	7.59
Current Portion of Leases	13.88	13.68	13.15	7.9	7.63
Current Unearned Revenue	-	-	-	1.09	0.08
Other Current Liabilities	14.15	4.06	9.55	2.85	2.35
Total Current Liabilities	29.38	31.73	38.66	22.5	18.5
Long-Term Debt	24.11	-	-	-	75.5
Long-Term Leases	43.9	50.09	62.23	11.27	19.17
Long-Term Deferred Tax Liabilities	0.15	0.15	-	-	-
Other Long-Term Liabilities	-	-	-	1.46	-
Total Liabilities	97.53	81.97	100.89	35.23	113.17
Common Stock	562.41	560.45	557.95	444.94	299.72
Additional Paid-In Capital	612.48	581.43	580.17	239.16	3.84
Retained Earnings	-894.88	-814.27	-655.53	-440.82	-316.62
Comprehensive Income & Other	-0.19	27.09	10.39	0.99	0.07
Shareholders' Equity	279.82	354.7	492.99	244.27	-12.99
Total Liabilities & Equity	377.35	436.66	593.88	279.5	100.18
Total Debt	81.89	63.78	75.38	19.17	102.3
Net Cash (Debt)	82.59	153.23	376.48	211.39	-61.48
Net Cash Growth	-78.06%	-59.30%	78.10%	-	-
Net Cash Per Share	1.47	2.74	7.77	6.00	-2.05
Filing Date Shares Outstanding	56.37	56.05	52.02	44.49	29.97
Total Common Shares Outstanding	56.37	56.05	52.02	44.49	29.97
Working Capital	156.48	204.03	427.8	220.38	35.18
Book Value Per Share	4.96	6.33	9.48	5.49	-0.43
Tangible Book Value	277.74	352.31	492.47	244.11	-13.15
Tangible Book Value Per Share	4.93	6.29	9.47	5.49	-0.44
Machinery	-	99.07	42.81	32.36	33.22
Leasehold Improvements	-	79.08	41.5	40.82	40.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.